Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.
Autor: | Waid TH; Department of Medicine, University of Kentucky, Lexington., Lucas BA, Thompson JS, Munch LC, Brown S, Kryscio R, Prebeck R, VanHoy MA, Jezek D |
---|---|
Jazyk: | angličtina |
Zdroj: | Transplantation proceedings [Transplant Proc] 1991 Feb; Vol. 23 (1 Pt 2), pp. 1062-5. |
Databáze: | MEDLINE |
Externí odkaz: |